Work

How good a predictor the in vitro antibiogram is, of in vivo antibiotic efficacy? An in vitro - in vivo integrated approach

Year: 2026
Type: preprint
Abstract: Conventional antimicrobial susceptibility testing, particularly the disc diffusion assay (DDA), provides a convenient means of assessing bacterial susceptibility to antibiotics. However, its ability to predict antibiotic efficacy in an infected host remains uncertain. This study investigated the relationship between DDA-derived inhibition zones and host-protective antibiotic activity using Caenorhabditis elegans infection models involving three bacterial pathogens: methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa , and Clostridioides difficile . A total of 42 antibiotics were evaluated through DDA, while a separate panel of 75 antibiotics was screened using an automated C. elegans infection assay. Twenty-six antibiotics common to both panels were selected for comparative analysis. Gnotobiotic L3-L4 stage worms were challenged with individual pathogens in the presence of each antibiotic at a fixed concentration of 9.6 µg/mL. Worm activity was quantified at 24, 48, and 72 h using an automated worm tracker system, with appropriate health, infection, vehicle, and antibiotic-toxicity controls. Overall, DDA-derived zone of inhibition (ZOI) diameters showed weak-to-moderate, pathogen- and time-dependent correlations with worm activity. At 24 h, Pearson’s correlation coefficients ranged from −0.20 to 0.31 across the three pathogen-host systems, while at 48 h they ranged from −0.009 to 0.49. Notably, antibiotic rankings based on DDA and host-protective activity differed considerably. For example, against C. difficile , imipenem produced the largest inhibition zone (41 mm) but failed to protect worms at 24 and 48 h, whereas tobramycin, despite producing a smaller inhibition zone (26 mm), exhibited the highest early worm activity. Similar discrepancies were observed with the other pathogens. These findings demonstrate that DDA-derived susceptibility profiles do not consistently predict antibiotic-mediated protection in an infected host. The C. elegans model may therefore serve as a complementary whole-organism screening platform, providing additional functional information for prioritizing antimicrobial agents beyond conventional in vitro susceptibility testing.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7236477537
Cites: 15
Cited by:
Related to: 10